← Eichor
Study identifier: NCT06713850 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

Condition: Peripheral Artery Disease (PAD) · Chronic Limb Threatening Ischemia  ·  Sponsor: Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

PhaseN/A
Planned participants130
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

There is a lack of prospective observational studies of shockwave balloons in the treatment of moderate-to-severe calcification of the femoral popliteal artery at the international level. Therefore, in this study, we wish to set up a real-world study of shockwave balloon in the treatment of moderate-to-severe calcification to investigate the real-world efficacy of shockwave balloon in the treatment of moderate-to-severe calcified lesions.

This description comes directly from the study's public registry record.

Talk to the study team

Zibo Feng, MD  ·  86-13545160302  ·  fengzibo@hust.edu.cn

Ye Du, DM  ·  86-15827105515  ·  duye@hust.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Liyuan Hospital of Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06713850